ATF3 and lung carcinoma: Nonetheless, other molecules implicated in this signaling pathway, such as ATF3 [36] and MKP1, which has been related to both “de novo” and acquired resistance to cDDP in ovarian and lung cancer models [17], [37] should be considered in the final role of p38 MAPK in cDDP resistance.